Literature DB >> 30904044

Impact of Cirrhosis on Pneumonia-Related Outcomes in Hospitalized Older Veterans.

Zachary Boivin1, Mario F Perez1, Nkiruka C Atuegwu1, Antonio Anzueto2, Eric M Mortensen3.   

Abstract

BACKGROUND: Prior research has demonstrated high mortality rates in patients with cirrhosis who contract bacterial infections. The purpose of our study was to explore clinical outcomes such as 90-day mortality, rehospitalization, and intensive care unit (ICU) admission in older veterans with pneumonia and cirrhosis.
METHODS: We conducted a retrospective cohort study of hospitalized patients with community-acquired pneumonia at any Departments of Veterans Affairs (VA) hospital over a 10-year period. We included patients 65 years or older who consistently received VA care and who were diagnosed with community-acquired pneumonia. There were 103,997 patients who met the inclusion criteria, and 1,246 patients with cirrhosis. We used multilevel regression models to examine the association between cirrhosis and the outcomes of interest after controlling for potential confounders.
RESULTS: Cirrhosis was associated with significantly increased odds of 90-day mortality (odds ratio 1.79, 95% confidence interval, 1.57-2.04). There were also significantly increased odds of rehospitalization within 90-days (1.30, 1.16-1.47). No significant association was found with ICU admission (1.00, 0.83-1.19).
CONCLUSIONS: We found an association between cirrhosis and 90-day mortality and rehospitalization in older patients with pneumonia. We suggest that physicians should carefully monitor patients with cirrhosis who develop pneumonia.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Cirrhosis; Mortality; Pneumonia; Rehospitalization

Mesh:

Year:  2019        PMID: 30904044      PMCID: PMC6863737          DOI: 10.1016/j.amjms.2019.01.004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  26 in total

1.  VistA--U.S. Department of Veterans Affairs national-scale HIS.

Authors:  Steven H Brown; Michael J Lincoln; Peter J Groen; Robert M Kolodner
Journal:  Int J Med Inform       Date:  2003-03       Impact factor: 4.046

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores.

Authors:  Diego Viasus; Carolina Garcia-Vidal; Jose Castellote; Jordi Adamuz; Ricard Verdaguer; Jordi Dorca; Frederic Manresa; Francesc Gudiol; Jordi Carratalà
Journal:  Medicine (Baltimore)       Date:  2011-03       Impact factor: 1.889

4.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

Review 5.  Bacterial infections in cirrhosis: A critical review and practical guidance.

Authors:  Chalermrat Bunchorntavakul; Naichaya Chamroonkul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2016-02-28

6.  Quality of care, process, and outcomes in elderly patients with pneumonia.

Authors:  T P Meehan; M J Fine; H M Krumholz; J D Scinto; D H Galusha; J T Mockalis; G F Weber; M K Petrillo; P M Houck; J M Fine
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

7.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

8.  Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.

Authors:  D Goldberg; Jd Lewis; Sd Halpern; Mark Weiner; Vincent Lo Re
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-06-04       Impact factor: 2.890

9.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

Review 10.  Bacterial infection-related morbidity and mortality in cirrhosis.

Authors:  Leonidas Christou; Georgios Pappas; Matthew E Falagas
Journal:  Am J Gastroenterol       Date:  2007-05-17       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.